APPLICATION
NDA205637
TYPE
NDA
ORIGINAL APPROVAL
2014-06-06
LATEST ACTION
2022-12-16
ROUTE
BUCCAL
DOSAGE FORM
FILM
MARKETING STATUS
Discontinued
Products
BUNAVAIL · ReferenceDiscontinued
BUPRENORPHINE HYDROCHLORIDE EQ 4.2MG BASE, NALOXONE HYDROCHLORIDE EQ 0.7MG BASE · FILM · BUCCAL
BUNAVAIL · ReferenceDiscontinued
BUPRENORPHINE HYDROCHLORIDE EQ 6.3MG BASE, NALOXONE HYDROCHLORIDE EQ 1MG BASE · FILM · BUCCAL
BUNAVAIL · ReferenceDiscontinued
BUPRENORPHINE HYDROCHLORIDE EQ 2.1MG BASE, NALOXONE HYDROCHLORIDE EQ 0.3MG BASE · FILM · BUCCAL
Approval history
2018-01-25Labeling · Supplement 1 · standardAP
2015-10-14Manufacturing (CMC) · Supplement 6 · standardAP
2015-04-24Manufacturing (CMC) · Supplement 3 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.